|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,100.00 GBX | +15.79% |
|
0.00% | +5.56% |
| 05-29 | WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership | AN |
| 05-18 | Braime Group PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 16.8M 22.55M 19.43M 17.89M 31.54M 2.13B 31.88M 211M 82.37M 1.04B 84.62M 82.82M 3.62B | P/E 2024 |
6.63x | P/E 2025 | 4.78x |
|---|---|---|---|---|---|
| Enterprise Value | 20.9M 28.04M 24.17M 22.25M 39.23M 2.65B 39.64M 263M 102M 1.3B 105M 103M 4.5B | EV / Sales 2024 |
0.43x | EV / Sales 2025 | 0.38x |
| Free-Float |
53.56% | Yield 2024 |
1.45% | Yield 2025 | 1.83% |
| 25-09-02 | Braime : 2025 Interim Report | PU |
| 21-09-08 | Braime : 2021 Interim Report.pdf | PU |
| 20-09-18 | Braime : 2020 Interim Report_0.pdf | PU |
| 20-05-28 | Braime : 2019 Annual Report.pdf | PU |
| 1 month | +11.76% | ||
| 3 months | +35.71% | ||
| 6 months | +11.76% | ||
| Current year | +5.56% |
| 1 week | 800 |  | 1,100 |
| 1 month | 700 | | 1,100 |
| Current year | 500 | | 1,200 |
| 1 year | 500 | | 1,200 |
| 3 years | 500 | | 1,590 |
| 5 years | 500 | | 2,600 |
| 10 years | 500 | | 2,799.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alan Braime
CEO | Chief Executive Officer | 45 | 2023-01-31 |
Carl Braime
CEO | Chief Executive Officer | 47 | 2023-01-31 |
Cielo Cartwright
DFI | Director of Finance/CFO | 63 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Braime
BRD | Director/Board Member | 45 | 2010-08-15 |
Carl Braime
BRD | Director/Board Member | 47 | 2010-08-15 |
Oliver Braime
CHM | Chairman | 76 | 1971-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +15.79% | 0.00% | +2.70% | -35.59% | 22.55M | |
| +1.88% | +8.29% | +45.38% | +155.00% | 118B | |
| +1.55% | +5.53% | +95.19% | +43.28% | 43.04B | |
| +1.88% | +13.15% | -1.11% | +24.37% | 30.73B | |
| +1.85% | +5.67% | +28.28% | +57.48% | 29.98B | |
| +1.54% | +9.04% | +41.01% | +49.49% | 28.87B | |
| +5.17% | +16.20% | +39.43% | -11.41% | 27.16B | |
| +0.62% | +4.65% | -10.58% | -1.01% | 26.63B | |
| +2.16% | +10.61% | - | - | 25.68B | |
| +0.63% | +3.55% | +37.15% | +43.12% | 23.97B | |
| Average | +1.72% | +3.76% | +30.83% | +36.08% | 35.44B | |
| Weighted average by Cap. | +1.87% | +4.06% | +39.99% | +75.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 48.95M 65.69M 56.61M 52.13M 91.9M 6.21B 92.87M 616M 240M 3.04B 247M 241M 10.54B | 50.94M 68.36M 58.91M 54.25M 95.63M 6.46B 96.64M 641M 250M 3.17B 257M 251M 10.97B |
| Net income | 2.28M 3.06M 2.64M 2.43M 4.28M 289M 4.33M 28.69M 11.18M 142M 11.48M 11.24M 491M | 2.71M 3.64M 3.14M 2.89M 5.1M 344M 5.15M 34.16M 13.31M 169M 13.67M 13.38M 584M |
| Net Debt | 3.32M 4.46M 3.84M 3.54M 6.24M 422M 6.31M 41.83M 16.3M 207M 16.74M 16.39M 716M | 4.09M 5.5M 4.74M 4.36M 7.69M 520M 7.77M 51.54M 20.08M 254M 20.63M 20.19M 882M |
Employees
211
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-17 | 1,100.00 p | +15.79% | 301 |
| 26-06-16 | 950.00 p | 0.00% | 113 |
| 26-06-15 | 950.00 p | 0.00% | 102 |
| 26-06-12 | 950.00 p | 0.00% | 0 |
| 26-06-11 | 950.00 p | 0.00% | 0 |
- Stock Market
- Stocks
- BMT Stock
Select your edition
All financial news and data tailored to specific country editions
